AOD-9604 and Tesamorelin in Combination Research The theoretical basis for discussing AOD-9604 alongside Tesamorelin comes from their non-overlapping mechanisms: AOD-9604 acts locally on fat tissue without engaging the GH/IGF-1 axis, while Tesamorelin works upstream by stimulating pituitary GH release
For example, a study published in the Journal of Alternative and Complementary Medicine found that B12 supplements improved endurance and reduced fatigue in athletes
For trial details see the Motus study
Hepatology 56 , 21882198 (2012)
[6] The most defensible description is that AOD9604 was associated with beta-3-adrenergic-receptor-related adaptations in mouse adipose tissue, while the direct molecular target responsible for the reported metabolic effects remained unresolved
The semaglutide bottle(s), syringes (individually wrapped), and alcohol pads, along with clear directions on storage and use